arBtrage CAPITALIZING MARKETS checking… Sign in

Autolus Therapeutics plc

AUTL Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$1.53
▼ -7.8% Today
as of Jun 7, 07:09 ET
Last 30 days +3.38% Apr 28 → Jun 05
$1.37 $1.51 $1.64 $1.77 $1.91 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$1.66
High
$1.66
Low
$1.50
Volume
$1M
Avg Vol
$2M
Mkt Cap
$471M
P/E (TTM)
Beta
52w High
$2.70
52w Low
$1.18
Div Yield
Shares Out

Overview

52-week range
$1.18
$2.70
23% of range
Avg surprise (last 2)
-0.7%
Avg reaction (last 2)
+1.4%
50% positive
Latest IV / EM
118%
EM ±16.3% · $2 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.31$-0.28$-0.24$-0.21$-0.18 Actual $-0.26Actual $-0.26Actual $-0.24Actual $-0.22Actual $-0.31Actual $-0.26Est $-0.24Actual $-0.18Actual $-0.30Actual $-0.27Est $-0.29 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-82M$-59M$-36M$-13M$9M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 14, 2026Mar/2026 $-0.27 $-0.29 +6.9% -3.9% -7.0% earnings
Tue Sep 30, 2025Sep 2025 $-0.30 financials
Mon Jun 30, 2025Jun 2025 $-0.18 financials
Thu May 8, 2025Mar/2025 $-0.26 $-0.24 -8.3% +9.8% earnings
Mon Sep 30, 2024Sep 2024 $-0.31 financials
Sun Jun 30, 2024Jun 2024 $-0.22 financials
Sun Mar 31, 2024Mar 2024 $-0.24 financials
Sat Sep 30, 2023Sep 2023 $-0.26 financials
Fri Jun 30, 2023Jun 2023 $-0.26 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$9M
Cost of revenue$25M$29M$24M$18M$0$0
Gross profit
Operating income$-60M$-72M$-61M$-65M$-68M$-59M
Net income$-72M$-79M$-48M$-70M$-82M$-58M
EPS (diluted)$-0.27$-0.30$-0.18$-0.26$-0.31$-0.22

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$131M$104M$86M$124M$96M$227M$657M$706M
Inventory$33M$33M$28M$24M$15M$4M
Total current assets$369M$436M$515M$574M$616M$661M$718M$759M
Total assets$527M$589M$662M$721M$746M$783M$827M$854M
Long-term debt
Total liabilities$418M$411M$396M$375M$375M$355M$351M$326M
Total equity$109M$178M$265M$346M$371M$427M$477M$528M

Implied volatility — last 90 days

112%115%117%120%122% Jun 07 — IV 118% · EM ±16.3%

Sector peers